Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1964 1
1965 14
1966 21
1967 38
1968 41
1969 49
1970 51
1971 67
1972 71
1973 91
1974 104
1975 81
1976 89
1977 88
1978 63
1979 79
1980 135
1981 106
1982 86
1983 110
1984 151
1985 183
1986 172
1987 179
1988 187
1989 173
1990 219
1991 176
1992 166
1993 183
1994 189
1995 196
1996 262
1997 291
1998 265
1999 336
2000 371
2001 404
2002 472
2003 581
2004 616
2005 749
2006 779
2007 798
2008 818
2009 908
2010 1019
2011 1109
2012 1181
2013 1257
2014 1323
2015 1288
2016 1206
2017 1148
2018 1148
2019 1233
2020 1300
2021 1426
2022 1311
2023 1252
2024 499

Text availability

Article attribute

Article type

Publication date

Search Results

25,884 results

Results by year

Filters applied: . Clear all
Page 1
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.
Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, Bryce A, Chapin B, Cheng HH, D'Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Gupta S, Guzzo T, Ippolito JE, Kuettel MR, Lang JM, Lotan T, McKay RR, Morgan T, Netto G, Pow-Sang JM, Reiter R, Roach M, Robin T, Rosenfeld S, Shabsigh A, Spratt D, Teply BA, Tward J, Valicenti R, Wong JK, Shead DA, Snedeker J, Freedman-Cass DA. Schaeffer EM, et al. J Natl Compr Canc Netw. 2023 Oct;21(10):1067-1096. doi: 10.6004/jnccn.2023.0050. J Natl Compr Canc Netw. 2023. PMID: 37856213
Epigenetic modulations and lineage plasticity in advanced prostate cancer.
Ge R, Wang Z, Montironi R, Jiang Z, Cheng M, Santoni M, Huang K, Massari F, Lu X, Cimadamore A, Lopez-Beltran A, Cheng L. Ge R, et al. Ann Oncol. 2020 Apr;31(4):470-479. doi: 10.1016/j.annonc.2020.02.002. Epub 2020 Feb 13. Ann Oncol. 2020. PMID: 32139297 Free article. Review.
[Vorwort].
von Amsberg G, Gschwend JE. von Amsberg G, et al. Oncol Res Treat. 2020;43 Suppl 2:5. doi: 10.1159/000507053. Epub 2020 May 19. Oncol Res Treat. 2020. PMID: 32428911 Free article. German. No abstract available.
Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer.
Hawley JE, Obradovic AZ, Dallos MC, Lim EA, Runcie K, Ager CR, McKiernan J, Anderson CB, Decastro GJ, Weintraub J, Virk R, Lowy I, Hu J, Chaimowitz MG, Guo XV, Zhang Y, Haffner MC, Worley J, Stein MN, Califano A, Drake CG. Hawley JE, et al. Cancer Cell. 2023 Nov 13;41(11):1972-1988.e5. doi: 10.1016/j.ccell.2023.10.006. Epub 2023 Nov 2. Cancer Cell. 2023. PMID: 37922910 Free article.
Bipolar androgen therapy (BAT): A patient's guide.
Denmeade S, Antonarakis ES, Markowski MC. Denmeade S, et al. Prostate. 2022 May;82(7):753-762. doi: 10.1002/pros.24328. Epub 2022 Mar 31. Prostate. 2022. PMID: 35357024 Free PMC article. Review.
The Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Oligometastatic Hormone-sensitive Prostate Cancer: A Post Hoc Analysis of ARCHES.
Armstrong AJ, Iguchi T, Azad AA, Villers A, Alekseev B, Petrylak DP, Szmulewitz RZ, Alcaraz A, Shore ND, Holzbeierlein J, Gomez-Veiga F, Rosbrook B, Zohren F, Haas GP, Gourgiotti G, El-Chaar N, Stenzl A. Armstrong AJ, et al. Eur Urol. 2023 Aug;84(2):229-241. doi: 10.1016/j.eururo.2023.04.002. Epub 2023 May 12. Eur Urol. 2023. PMID: 37179240 Free article. Clinical Trial.
Vaccines as treatments for prostate cancer.
Rastogi I, Muralidhar A, McNeel DG. Rastogi I, et al. Nat Rev Urol. 2023 Sep;20(9):544-559. doi: 10.1038/s41585-023-00739-w. Epub 2023 Mar 6. Nat Rev Urol. 2023. PMID: 36879114 Free PMC article. Review.
Non-metastatic castration-resistant prostate cancer: management recommendations.
Alcaraz Asensio A, Alvarez Ossorio JL, Cozar Olmo JM, Chantada Abal V, Juarez Soto A, Linares Espinos E, Moreno Jimenez J, Muñoz Rodriguez J, Perez Fentes D, Plata Bello A, Rodrigo Aliaga M, Unda Urzaiz M, Vilaseca A. Alcaraz Asensio A, et al. Actas Urol Esp (Engl Ed). 2022 May;46(4):193-213. doi: 10.1016/j.acuroe.2021.11.001. Epub 2022 Mar 16. Actas Urol Esp (Engl Ed). 2022. PMID: 35305957 Review. English, Spanish.
[Systemic treatment of advanced prostate cancer].
Kretschmer A, Todenhöfer T. Kretschmer A, et al. Urologe A. 2020 Dec;59(12):1565-1576. doi: 10.1007/s00120-020-01381-9. Urologe A. 2020. PMID: 33201295 Review. German.
25,884 results
You have reached the last available page of results. Please see the User Guide for more information.